Patient-derived xenografts (PDXs) are fast becoming the new gold standard models for oncological drug development. Learn more from Anne-Lise Peille, Laboratory Head of Biobanking and Molecular Analytics at Oncotest, a Charles River company, in Freiburg, Germany.
Charles River will become the preferred drug discovery and preclinical development partner for BioMotiv through the partnership—designed to help the accelerator translate discoveries from portfolio companies formed to commercialize technologies sourced from academic research and nongovernmental organizations.
BioMotiv LLC of Shaker Heights has secured an investment from Wilmington, Mass.-based Charles River Laboratories International Inc. that could reach up to $10 million. As part of the agreement, Charles River will provide preclinical development services that will help BioMotiv advance discoveries sourced from academic research and non-governmental organizations into new medicines.
Bill Barbo, Senior Vice President of Global Sales and Marketing for Charles River, discusses the acquisition of WIL Research and the role the company is playing in advancing immunotherapy research.
Demand for biological products has driven recent Charles River investments in vaccine manufacturing and cell banking. Part of this investment includes expanding sites in both Pennsylvania and Germany to meet client needs.
Ruth Burns and Alison Dickson from Charles River recently spoke with Bioanalysis Zone about the importance of competition and attending conferences for scientists beginning their careers.
The Boston Globe recently featured an article describing Charles River Laboratories. Speaking with James Foster, Chairman and CEO, the article details the Charles River portfolio and the services offered to biotech and pharma companies.
Recently, we announced our renewed partnership with the Michael J. Fox Foundation to study Parkinson's disease. Check out this article in Bioscience Technology to learn more about our work from David Fischer and Robert Hodgson.
Our bodies contain vastly more microbes than there are stars in the Milky Way—about 100 trillion microbes just in the gut of any single person. Dr. Rana Samadfam, Scientific Director of In Vivo Pharmacology and Principal Scientist of Musculoskeletal Research at Charles River, discusses how microbes could help heal bones in a new Scientific American blog.
According to a new study, rest between mild head impacts helps brain recovery in mice. Patrick Sweeney, Managing Director of Charles River’s Discovery Research Services in Finland, discusses in STAT.